Shire PLC ORD 5P/ JE00B2QKY057 /
2019-01-07 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
4,690.0000GBX | - | 51,588 Turnover(GBP): - |
4,500.0000Bid Size: - | 4,800.0000Ask Size: - | 4,690.0000 | 4,690.0000 |
GlobeNewswire
2018-12-17
FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist for adults wit...
GlobeNewswire
2018-09-21
Shire Receives Approval of FIRAZYR® (icatibant injection) for the Treatment of Hereditary Angioedema...
GlobeNewswire
2018-09-20
Health Canada has authorized TAKHZYRO(TM) (lanadelumab injection), a first-of-its-kind monoclonal an...
GlobeNewswire
2018-09-12
Shire Granted EU Marketing Authorization for Veyvondi® for Adults With Von Willebrand Disease
GlobeNewswire
2018-09-10
SHIRE ANNOUNCES THE PRICING TERMS AND INCREASE IN THE MAXIMUM TENDER AMOUNT OF THE PREVIOUSLY ANNOUN...
GlobeNewswire
2018-09-10
SHIRE ANNOUNCES EARLY RESULTS OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING...
GlobeNewswire
2018-09-06
Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise
GlobeNewswire
2018-08-24
SHIRE ANNOUNCES CASH TENDER OFFERS FOR UP TO $2,250,000,000 OUTSTANDING PRINCIPAL AMOUNT OF NOTES
GlobeNewswire
2018-08-23
Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Tre...
GlobeNewswire
2018-08-13
New Drug Application Submitted in Japan for INTUNIV® (guanfacine hydrochloride extended release) in ...
GlobeNewswire
2018-06-22
Shire plc: Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Tr...
GlobeNewswire
2018-06-21
Shire Receives U.S. FDA Approval for New State-of-the-Art Plasma Manufacturing Facility Near Covingt...
GlobeNewswire
2018-06-21
Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric ...
GlobeNewswire
2018-05-22
Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology